Alpine Immune Sciences (ALPN) Reports Q2 Loss of $0.53/sh

Alpine Immune Sciences (NASDAQ: ALPN) reported Q2 EPS of ($0.53), versus ($0.64) reported last year. Revenue for the quarter came in at $10.44 million, versus $12.72 million reported last year.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• EU opens antidumping review of Chinese silicon metal imports
• GitLab Inc (GTLB) Tops Q2 EPS by 7c, Beats on Revenue